These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 10908004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM, Taylor JA, Gallagher C, Dawud-Noursi S.
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [Abstract] [Full Text] [Related]

  • 3. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson R, Ling W.
    J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
    [Abstract] [Full Text] [Related]

  • 4. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL, McCann MJ, Marinelli-Casey P, Weiner A, Minsky S, Brethen P, Rawson R.
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [Abstract] [Full Text] [Related]

  • 5. Methamphetamine abuse: issues for special populations.
    Freese TE, Obert J, Dickow A, Cohen J, Lord RH.
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [Abstract] [Full Text] [Related]

  • 6. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
    Reiber C, Galloway G, Cohen J, Hsu JC, Lord RH.
    J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conducting trials in community settings: the provider perspective.
    Zweben JE, Cohen JB, Obert J, Vandersloot D, Marinelli-Casey P.
    J Psychoactive Drugs; 2000; 32(2):193-9. PubMed ID: 10908007
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J, Methamphetamine Treatment Project Corporate Authors.
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [Abstract] [Full Text] [Related]

  • 12. Moving research into community settings in the CSAT methamphetamine treatment project: the coordinating center perspective.
    Rawson RA, McCann MJ, Huber A, Marinelli-Casey P, Williams L.
    J Psychoactive Drugs; 2000 Jun; 32(2):201-8. PubMed ID: 10908008
    [Abstract] [Full Text] [Related]

  • 13. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [Abstract] [Full Text] [Related]

  • 14. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
    Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C.
    Drug Alcohol Depend; 2005 May 09; 78(2):125-34. PubMed ID: 15845315
    [Abstract] [Full Text] [Related]

  • 15. History of the methamphetamine problem.
    Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S.
    J Psychoactive Drugs; 2000 May 09; 32(2):137-41. PubMed ID: 10908000
    [Abstract] [Full Text] [Related]

  • 16. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.
    J Ment Health Policy Econ; 2007 Mar 09; 10(1):3-13. PubMed ID: 17417043
    [Abstract] [Full Text] [Related]

  • 17. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK, Liu LM, Muramoto M.
    Addiction; 2008 Jul 09; 103(7):1174-86. PubMed ID: 18422822
    [Abstract] [Full Text] [Related]

  • 18. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP, Simon SL, Rawson RA, Huber A, Ling W.
    J Psychoactive Drugs; 2000 Jul 09; 32(2):229-32. PubMed ID: 10908012
    [Abstract] [Full Text] [Related]

  • 19. [Abuse of "pheticol" and its interference to the analysis of methamphetamine].
    Shen M, Xiang P, Huang Z, Liu W, Shen B, Bu J.
    Fa Yi Xue Za Zhi; 1998 Jul 09; 14(3):129-31, 190. PubMed ID: 11938882
    [Abstract] [Full Text] [Related]

  • 20. Methamphetamine abuse.
    Winslow BT, Voorhees KI, Pehl KA.
    Am Fam Physician; 2007 Oct 15; 76(8):1169-74. PubMed ID: 17990840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.